dimethylmyleran has been researched along with EHS Tumor in 2 studies
dimethylmyleran: RN given refers to cpd without isomeric designation
dimethylmyleran : A methanesulfonate ester that is hexane-2,5-diol in which the hydrogens of the hydroxy groups are replaced by methanesulfonyl groups.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Floersheim, GL | 2 |
| Torhorst, J | 1 |
2 other studies available for dimethylmyleran and EHS Tumor
| Article | Year |
|---|---|
Inhibition by lymph node cells and promotion by fetal hepatocytes of murine tumours without or with chemotherapy.
Topics: Ancitabine; Animals; Antineoplastic Agents; Busulfan; Carcinogens; Cyclophosphamide; Female; Killer | 1981 |
Treatment of murine tumors with lethal doses of dimethylmyleran and autologous bone marrow.
Topics: Animals; Bone Marrow Transplantation; Busulfan; Female; Leukemia, Experimental; Mice; Mice, Inbred B | 1981 |